USD 15.53
(-7.39%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -127.81 Million USD | 0.64% |
2022 | -128.63 Million USD | 27.76% |
2021 | -178.07 Million USD | -2870.34% |
2020 | -5.99 Million USD | 79.67% |
2019 | -29.48 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | -19.52 Million USD | -6.2% |
2024 Q1 | -41.1 Million USD | 1.93% |
2024 Q2 | -18.38 Million USD | 55.28% |
2023 Q3 | -29.75 Million USD | -25.77% |
2023 FY | -127.81 Million USD | 0.64% |
2023 Q4 | -41.91 Million USD | -40.86% |
2023 Q2 | -23.65 Million USD | 27.18% |
2023 Q1 | -32.48 Million USD | 37.65% |
2022 Q1 | -36.47 Million USD | 16.08% |
2022 FY | -128.63 Million USD | 27.76% |
2022 Q4 | -52.1 Million USD | -55.96% |
2022 Q3 | -33.41 Million USD | -402.56% |
2022 Q2 | -6.64 Million USD | 81.77% |
2021 FY | -178.07 Million USD | -2870.34% |
2021 Q4 | -43.46 Million USD | -4.86% |
2021 Q3 | -41.45 Million USD | -2.37% |
2021 Q2 | -40.49 Million USD | 23.11% |
2021 Q1 | -52.66 Million USD | -89.47% |
2020 Q3 | 15.06 Million USD | 19.65% |
2020 Q2 | 12.58 Million USD | 346.08% |
2020 Q4 | -27.79 Million USD | -284.56% |
2020 Q1 | -5.11 Million USD | 0.0% |
2020 FY | -5.99 Million USD | 79.67% |
2019 FY | -29.48 Million USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Clover Health Investments, Corp. | -208.54 Million USD | 38.709% |
NewGenIvf Group Limited | 42.24 Thousand USD | 302682.738% |